Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Scai Therapeutics holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action. This action is being processed by 1 distinct examiner in 1 distinct art unit. JUSTICE, GINA CHIEUN YU is the busiest examiner, managing 1 pending office action. With 1 pending office action, the company's current patenting activity is highly specific.
The involvement of 1 distinct examiner, JUSTICE, GINA CHIEUN YU, means that the prosecution strategy is focused on a single set of examiner expectations. The 1 distinct art unit suggests that the Biotechnology & Pharmaceuticals subject matter is being reviewed within a specialized group. Practitioners should tailor their approach to the specific feedback from this examiner to move the 1 pending office action toward allowance. This focused approach allows for a dedicated response to the examiner's specific concerns regarding the 1 pending office action. Success in this 1 distinct art unit will be critical for the portfolio's development.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JUSTICE, GINA CHIEUN YU | 1 | 55.6% | +8.4% |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18251071 | SOLID CYCLOSPORIN A AND DISPERSION COMPOSITION COMPRISING SAME | JUSTICE, GINA CHIEUN YU | 1617 | §112 | Non-Final OA | — | Pending | Apr 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial